Bio-Fire Defense, LLC Reagents and Warranty FY25 Sole Source

The Illinois Department of Public Health (IDPH) is pursuing a sole source procurement for BioFire Defense, LLC reagents, testing kits, and warranty coverage for fiscal year 2025. The contract specifically involves purchasing 50 Global Fever Special Pathogens Panels, 10 BIOFIRE SHIELD Control Kits, 10 Gastrointestinal Panels, associated shipping, and a one-year extended warranty for six instruments. The procurement is focused on specialized diagnostic equipment capable of simultaneously detecting and identifying multiple pathogens within approximately one hour, with particular emphasis on infectious disease detection including Ebola, malaria, dengue, and Zika. The contract term is scheduled from May 1, 2025, to April 30, 2026. Key deadlines include a sole source hearing on March 21, 2025, at 2:00 pm, with written comments or hearing requests due by March 21, 2025, at 4:00 pm, and a final contract award date of March 26, 2025. Evaluation will center on BioFire's exclusive FDA Emergency Use Authorization for Laboratory Response Network (LRN) Ebola virus detection and their unique technological capabilities.

The procurement appears to be unrestricted in terms of set-aside designations, with BioFire Defense, LLC being the sole source vendor due to their proprietary technology and exclusive patents. The contract will be funded through state and federal resources, with a total contract value of $154,478. The existing infrastructure includes six BioFire FilmArray 2.0 instruments that will be covered under the new warranty, indicating a continuation of current technological investments. No specific disadvantaged enterprise requirements were mentioned in the documentation. The sole source justification is predicated on BioFire being the only FDA-approved system for certain pathogen detection, with exclusive authorization from the CDC and Department of Defense. This procurement aims to maintain IDPH's critical diagnostic capabilities, preserve Laboratory Response Network certification, and ensure continued eligibility for federal funding without incurring significant costs associated with replacing existing diagnostic infrastructure.